Drug Profile
RG 7342
Alternative Names: RG7342; RO 6806127Latest Information Update: 13 Oct 2015
Price :
$50
*
At a glance
- Originator Roche
- Class Antipsychotics; Small molecules
- Mechanism of Action Metabotropic glutamate receptor 5 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 23 Apr 2015 Discontinued - Phase-I for Schizophrenia (In volunteers) in USA (PO)
- 01 Jan 2015 Roche completes a phase I trial in Schizophrenia in USA (NCT02196636)
- 01 Jul 2014 Phase-I clinical trials in Schizophrenia (in volunteers) in USA (PO, Liquid)